Recent changes
- Aug 4, 2026Aug 4, 2026Invested in QuantHealth (Series B, $45M) HIT Consultant
Portfolio
4 totalRecent Investment Activity
2| Date | Company | Event | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|---|
| Aug 4, 2026 | QuantHealth | Series B | $45M | — | outlined = lead | Pulse story |
| Jul 24, 2026 | Scribe Therapeutics | IPO | $155.5M (incl. private placement) | — | Scribe Therapeutics |
Sector / Stage Activity
By sector (portfolio)
Biotech
3 · 75%
AI infra
1 · 25%
By stage (tracked rounds)
Series B
1 · 50%
IPO
1 · 50%
Co-Investors
12Deep Track Capital · 1 sharedEcoR1 Capital · 1 sharedFrazier Life Sciences · 1 sharedGoldman Sachs Alternatives · 1 sharedIllumina Ventures · 1 sharedNextech Invest · 1 sharedvenBio Partners · 1 shared5AM Ventures · 1 sharedAscenta Capital · 1 sharedBlue Owl Capital · 1 sharedForesite Capital · 1 sharedQatar Investment Authority · 1 shared
Sources & methodologyshow
Where these figures come from
- Scribe Therapeuticsprimary source1 fact
- HIT ConsultantValue Add VC data1 fact
Figures are labelled Reported (a source states it), Estimated, Derived (computed from other facts) or Rumored (in talks / unconfirmed). Rumors never replace a confirmed figure. Each figure keeps its own as-of date; history is preserved rather than overwritten.